A Clinical Investigation of Diltiazem's Effects on Renal Function in Undergoing Cardiopulmonary Bypass

HUANG Yong-gao,LIU Ji-chun,LIU Yin-fen
DOI: https://doi.org/10.3969/j.issn.1000-2294.2006.06.036
2006-01-01
Abstract:Objective Objective To investigate the effects of diltiazem on renal function in patients who underwent cardiopulmonary bypass. Methods Forty cases of ASA grade Ⅱ~Ⅲ undergoing replacement of valve under cardiopulmonary bypass were divided into two groups:Treated group(n=20)receiving a continuous intravenous infusion of diltiazem at 2 μg/(kg·min) from the beginning of CPB and continue for 1.5 hours.Control group(n=20)received no diltiazem.Cr clear ratio(CCR),urine-α_1-microglobulin,urine-β_2-microglobulin were measured before anesthesia,the duration of CPB,4 hours after CPB and 12 hours after CPB.Results ①Before anesthesia there is no remarkable difference between two groups in CCR,u-α_1-MG and u-β_2-MG(P>0.05).②In the end of CPB,4 hours after CPB,the level of CCR obviously decreased in the two groups respectively(P<0.05),and it was obviously lower in Control group than Treatment group(P<(0.05)),but it came back to the base line until 12 hours after CPB in two groups(P>0.05).③In the duration of CPB,4 hours after CPB,12 hours after CPB,the levels of u-α_1-MG and u-β_2-MG obviously increased in the two groups respectively(P<0.05),and it was obviously lower in Treatment group than Control group(P<0.05).Conclusion Cardiopulmonary bypass have a negative effect on renal function.Diltiazem has protection on renal function in patients who undergoing cardiopulmonary bypass.
What problem does this paper attempt to address?